Guidance

Clinical pathway for babies who screen positive for SCID

Following this clinical pathway will help immunology services and teams to make sure babies are referred into diagnostic testing in the required timescales.

Applies to England

Documents

Details

Guidance setting out the pathway for babies who are screen positive for severe combined immunodeficiency (SCID) and are referred into diagnostic services.

Other resources for immunology services and teams are available on the SCID screening evaluation page.

Contact the Public Health England (PHE) Screening helpdesk with any queries about this publication, making sure you include its full title.

Updates to this page

Published 20 August 2021
Last updated 27 August 2021 + show all updates
  1. Minor change to flow cytometry normal definition.

  2. Added a definition of flow cytometry in decision point 5.

  3. First published.

Sign up for emails or print this page